Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer
1999
5 Treatment and prognostic factors in acute myeloid leukaemia
1996
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Testicular Germ-Cell Cancer
1997 Standout
The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth
1992
A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.
1992
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation
2005
Clinical Pharmacokinetics of Cyclophosphamide
1991
Amifostine
2001
Amifostine in clinical oncology: current use and future applications
2002
Cumulative toxicities from cisplatin therapy and current cytoprotective measures
1998
Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.
1996
Anthrazykline in der Krebstherapie
1997 Standout
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Radioprotective effects of hesperidin against gamma irradiation in mouse bone marrow cells
2006
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Biochemical modulation of cisplatin toxicity
1989
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors
2000
A Randomized Trial Comparing the Nephrotoxicity of Cisplatin/Ifosfamide-Based Combination Chemotherapy with or without Amifostine in Patients with Solid Tumors
2000
The pathobiology of mucositis
2004 Standout
SEVERE NEUROTOXICITY, OTOTOXICITY AND NEPHROTOXICITY FOLLOWING HIGH-DOSE CISPLATIN AND AMIFOSTINE
2005
Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.
1991
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
2003 Standout
ACUTE MYELOID LEUKAEMIA IN THE ELDERLY: BIOLOGY AND TREATMENT
1993
Management of Metastatic Melanoma 2005
2006
Cisplatin: The first metal based anticancer drug
2019 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
1989 StandoutNobel
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients
2003
Pharmacokinetics of amifostine and its metabolites in patients
1997
Radioprotective Effects of 2-Imino-3-[(chromone-2-yl)carbonyl] thiazolidines against γ-Irradiation in Mice
2002
Modification of cisplatin toxicity with diethyldithiocarbamate.
1990
Toxicity antagonists in head and neck cancer
1998
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Head and Neck Cancer
2001 Standout
Cisplatin nephrotoxicity
2003 Standout
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
1994
Clinacanthus nutansExtracts Are Antioxidant with Antiproliferative Effect on Cultured Human Cancer Cell Lines
2013 Standout
All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]
1990 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Role of maintenance chemotherapy in acute promyelocytic leukemia
1987
In vitro antioxidant properties of rutin
2007 Standout
Interventions for preventing neuropathy caused by cisplatin and related compounds
2014
Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung Cancer
2003
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
2003 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine
2001
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
Amifostine: chemotherapeutic and radiotherapeutic protective effects
2001
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia.
1987
Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
1987 StandoutNobel
Platinum resistance: Laboratory findings and clinical implications
1993
Treatment of the Newly Diagnosed Adult with De Noyo Acute Myeloid Leukemia
1993
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIAL
1986
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
1993
Works of C Weiler being referenced
WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.
1987
WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial.
1986
A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemia
1984
Final report of the phase I trial of single-dose WR-2721 [S-2-(3-aminopropylamino)ethylphosphorothioic acid].
1986